Utility of HCV core antigen ELISA in the screening for hepatitis C virus infection in patients on hemodialysis

Indian Journal of Medical Microbiology

Volumn 24, Issue 1, 2006, Pages 55-57

  Reddy, A K ^a   Dakshinamurty, K V ^a   Lakshmi, V ^a  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Chronic renal failure; Core antigen; HCV; RNA

Indexed keywords

CORE PROTEIN; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS RNA;

ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; PREDICTION; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION;

EID: 33645532848     PISSN: 02550857     EISSN: 02550857     Source Type: Journal    
DOI: 10.4103/0255-0857.19897     Document Type: Article

References (14)

1. Galan F, Garcia MT, Lozano A, Benavides B, Ruiz FE, Iglesias RM. A 3 year follow up of HCV RNA viremia in hemodialysis patients. Nephrol Dial Transplant 1998;13:1211-4.
2. Iwasaki Y, Esumi M, Hosakawa N, Yanai M, Kawano K. Occasional infection of hepatitis C virus occurring in hemodialysis units identified by serial monitoring of the virus infection. J Hosp Infect 2000;45:54-61.
3. Saab S, Brezina M, Gitnick G, Martin P, Yee HF. Hepatitis C screening strategies in hemodialysis patients. Am J Kidney Dis 2001;38:91-7.
4. Pawlotsky JM. Use and interpretation of virological tests for hepatitis C. Hepatology 2002;36:s65-73.
5. Lai KN. Hepatitis C infection screening in hemodialysis units. Am J Kidney Dis 2001;38:186-8.
6. Lok AS, Chien D, Choo QL, Chan TM, Chiu EK, Cheng IK, et al. Antibody response to core, envelope and non structural hepatitis C virus antigens: Comparison of immunocompetent and immunocompromised patients. Hepatology 1993;18:497-502.
7. Tanaka Y, Takagi K, Fujihara T, Kitsugi K, Fujiwara K, Hiramatsu K, et al. High stability of enzyme immuno assay for hepatitis C core antigen-evaluation before and after incubation in room temperature. Hepatol Res 2003;26:261-7.
8. Reddy AK, Murthy KV, Lakshmi V. Prevalence of HCV infection in patients on hemodialysis: Survey by antibody and core antigen detection. Indian J Med Microbiol 2005;23:106-10.
9. Icardi G, Ansaldi F, Bruzzone BM. Novel approach to reduce the hepatitis C virus window period. Clinical evaluation of new enzyme linked Immunosorbent assay for hepatitis C core antigen. J Clin Microbiol 2001;39:3110-4.
10. Schiff ER, Medina MD, Khan RS. New perspectives in the diagnosis of hepatitis C. Semin Liver Dis 1999;19:3-15.
11. Cheney CP, Chopra S, Graham C. Hepatitis C. Infect Dis Clin N Am 2000;14:633-7.
12. Courouce AM, Le Marrec NL, Bouchardeau F, Razer A, Maniez M, Laperche S, et al. Efficiency of HCV core antigen detection during the pre seroconversion period. Transfusion 2000;40:1198-202.
13. Peterson J, Green G, Lida K, Caldwell B, Kerrison P, Bernich S, et al. Detection of hepatitis C core antigen in antibody negative window phase of hepatitis C infection. Vox Sang 2000;78:80-5.
14. Alias BM, Patel K, Dahari H, Beaucourt S, Larderie P, Blatt L, et al. Clinical utility of HCV core antigen quantification: A new indirect marker of HCV replication. Hepatology 2002;36:211-8.